Victory Capital Management Inc Harpoon Therapeutics, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020
SELL
$11.11 - $24.72 $21,808 - $48,525
-1,963 Closed
0 $0
Q1 2020

May 04, 2020
SELL
$10.74 - $16.32 $7,507 - $11,407
-699 Reduced 26.26%
1,963 $23,000
Q4 2019

Feb 04, 2020
BUY
$12.94 - $20.58 $11,736 - $18,666
907 Added 51.68%
2,662 $35,000
Q3 2019

Nov 12, 2019
BUY
$10.93 - $17.47 $19,182 - $30,659
1,755 New
1,755 $24,000

Others Institutions Holding HARP

# of Institutions
2
Shares Held
353K
Call Options Held
0
Put Options Held
0
View Full List

About Harpoon Therapeutics, Inc.

HARP Quotes by TradingView
  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email